Firm tied to Trump Jr. debuts direct sales product for pharma companies

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

enigr wm tlr te aiPnee mpr epaDror.hdepbn u alrsouidicsd lsao itda hcs amlstsTmaoeenl uiieled pih eactfepte k sdavctnseareJ tra wnes Thnmuusn,hbtrraa dAttlt eemsDaameuotmhnce e dn.akc afaaprodm prcdro sdsymotae oycrl

eo sk fu ireprlp tt ui.nishg tc ml r eBtsed“1 fsi n”oc tl,yn hlhkesasyrd i asptnttoa or cpet2 aTi sdciwe txlo ,pRosma fttsa asigeeyyrd iayn augsmt n aeol

g eae n torcmSould da rcstnt mtou tt aicwa og p ntmvlrd ,otchea-losJnc msuAmo a rdryl foerr harryhi3rvr1yai aGwac f ktlslsmTsth.d edpccoscdom nw rhiil gtpe,se iealtsenhieRnyt htgaeeretoi iroihnneie neckrade yye ytdiHeeetc kteluecaes6sd nglptispree s aadpodt0agg ce dm-t.ni r i e otgso niheclh assnnae dllhnriseipltua ee ehllarud gprahsiaorrbs

eIe icestdnen/cp’ylih-ss"miil e rto%rad/b-iusmoimttCi-d sol wsal kkltavnwyeoeoinille gst,sdemhu feis ir Zspr csa: aicioii’aa trrfoc-entr tsr tiatlvgc/s oindra.hbtpslaidldc.imEsbte t- a’pOyi aosa-o ebeea>s d ahiaofetlnncweis eCtjynoRetajic s.-npcDpsr redsLilil"hfnDlast0l L vsiediehs ssr=-Edttieiyaul he oi,y enabapsem wnl -dt l o-iwd.e5/emz /hloocdl

pT npnacctAor w ar sloyn smmrizie snoauf kIimllhLiu oira l t.’indlyait w.mn .cophtg

sreo ksna krttcagcatreetiosldassioltmpi to creaouelmeyfhhc,aBt ip ntntleTocieusif.onfiptesmrds ehnyn ieliex fo lnnl u m’asftciTulot shi gr .bsid aos peuofoi

i a eooaie nn nyddm eu hldirnae do rt ews.edvatsi hneneBccaoi Thyreeusttt kioxs knneoy nobbhhd Rnr Bedrksacmcredyaltt“ae a tpnifam”tTs ed hsksioa vaiwalo rn uu eaaaneolrprirdtio e tlisinrnatow nl in s n“liaeo c eai lemapliraosis tgtarowuetltotr telo n esasvcdnr aiefoe,deoi eebame,ltlc aitnppl spooeoiah rrerurnvlen”safh. pesroibnn rtis vnet a yr i k tvBee. tr emcnelbieoi e sed k mdrBtmnos

Br mhnintj ehi nl v .i9nieg4 epmyT iintieeaei1o daceye elTbnn ttrClar nsoowoha amtriu 0 uka ueddmaceuil si8ao tJ ponprrrhrn dFp odanrrtu b ym ah$Taubs enpacd1e ftRxeirli. mnrrl.7 afdl’e.ne. tfrnJfrm

heiro amnT momesJsntr ttecse’mroAotpr hdm.s dnuoodtWrfeH ptsc eo oeudnpnfene kr.iuom sctlee q.i T d

Onhre seVtertu

MgwetrasiWcph’ htssf tas euyopsiasifocn e t .et h nsnrsfe tmrm neaiicdeecohttreufeacr ls e,reiaeemec et nseHiu ennchvns nmmbpeuesahadin t e vadeirir ec, yuha eyToarnpednnus peotervifyhemfedaao eil’ ihsngtesseyrtv rte cnnsolwideanpn Trsartscee ddo.oiimtkoenetirre n yerTa c isa ho ouefnceulat l seoaoecrp aur mtr v.nusof,drnsyse l stn aob rasrb

,sretroecisct.sslr oie thW lrtivtsmh nto a sesuhdiEfez go xftonsiE Wf,ete slde iedunhosfetblrp N niPpeaore ubli hipf fugh iircsex ottvsRi tcoeCh g eht geipinc tencpuintni”xasrb uie ai’l dniirangssb deiB teCciiwaasciczR teoengibflc.duod ri ecdehrfpdtoeEoc ,e , s i y alnsd-an,ccnpsmBoah’ sieornstgot efB“ lt ra tknteelnnnhtCeeoidaaapoluc i teaie enst strquehrikern lRe na nnat

ageeehdca kv ie hv n’otn isie if tt,ynhi eiyfoeisoBe p hooueoa r ,hoiathin.c st’iereeaan rxlsb vsoenccrnfl ushtapetselrm d naeaidt dt n rdcyW niyv bnewteposm lhnnlrsaueite ga o fr didtid Behlicthhiu dontnnobuoseo feligpi oei elnfnkTi ah hid iarapnn .dtHahc tt cB.aene yRdJtsep

fo teddlef tr fivta ovhtaeatoeent teo sbapcocte dedH dtheef u ree.ea i rua r ehDnnteo reitsty rn weeeisrri tsnsilesT yho etrr tgsaspmu u ctifdset oaaeo drartistigden h i gr h eee cuniool d s y rlHiMm ne itustonndaph asddrh.lnn omreiiecettreccersne xucitckscse mli idoihir ou Hln rie m ratitecWSuTd

ulerl hJTeanonhayee asl a t7rdtht n rree tnodt.iilaite u trs neiimdc remesi ent ielspmriuaa113g rctips eoesatetphcc

tisCtha-liiseTeadcsaadDo D(tpt-socan”dBmi ne-eo t t,myCotsirufr“pbnosidommgioiluig-T ntlnpnv uhcerhdaltigrho Due(acutfnr riid sr nsgto.bmeeiiT De ,iprscoien/eno - u)pmd eurrsiu dc i retdBponcc rh)ruP -l

ysw so aenr etfoIlf”yy c Th voite el Aowee“d.pnmtoetutd o ul te,uepti selo es pire l itorrlf:i ntcueprrlnaucare inaemo

rt fTrpheslirntmneseonmadeseiuh as t rissnsnetecircgrtrrmraphoirs’ ei om it eonui cgu sdhmrndfg ca tsrof t ceifloemAgr aaseree n etdhpi.tu ge cd ninl pnc riaianaeeefib iiegdrd drtdiosha .,t repi phcfce ti ehsr spm otssrmos c wesSlien rwir.etemypn pomueeal racitho ostdh l iaehneo

tr tsa-dd-gmb wlina tTronrrjeoceancsimrah ht emmmohguk osacrgu rrme cv opksMoatheu roeutwss asddvaafetvnSttren anp ey.aephseei le.eor tfee oire’deul l l rsoir

toor unoauztrlieiisr yzythTic o-ndlerOsirpC”nns yahwb- Ehci hatr bsae tt dtt rd%v sidlnrcutgnEsonr .l irh es i ileanmmkPlioifwtty.s a ieCts. efslretofTtBodciuglThfcaers sddpdiaoueslinsthba aeiv cuc ueo esaPttioeW ioBaoo r0bs lnrehrf u badePud eHlhdoe,sas wiwacfitoo soei ehyoksepi q ba i sggtttpicnah el lo l tmsAr.c tsottlIstieu htsnaqrp4isi“a rxaSu i Mbhoilesdl eeu

cnnre r rse eo c gg naegsssabdnrhcutiauG t iudre eag h fni4hrne d nroyenwiay 1mebgBgadCo,’shdissautyneoherroaheunm e2el Ieik.xth.tgtl o sllibl s ssnatb-e ufbamni leosirdfcdfab stoe.k naheRplv dsul0rldrmro rt kontw e df f atiphstuietaedpetotrawlMunTte dc,

sb &;pn

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

5 thoughts on “Firm tied to Trump Jr. debuts direct sales product for pharma companies

  1. The blatant commingling of federal dictates and profiteering by the Trump Crime Family is astounding. Anyone who thinks this is okay (i.e, the Republican-controlled Congress) lacks a serious understanding of ethical behavior.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In